BRITNEY FRIESENHAHN: Open Payments
NPI 1073817078 · NAVASOTA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 24 payments from 11 companies in 2025. Trend: 2023 $151 · 2024 $69 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $146 |
| Medtronic, Inc. | 1 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Novo Nordisk Inc | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $28 |
| Lilly USA, LLC | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| OWP Pharmaceuticals, Inc. | 1 | $16 |
Products named: VRAYLAR, INCEPTIV, Kerendia, CAPLYTA, SHINGRIX, Ozempic, Rybelsus, MOUNJARO.
Industry payments across TX — which companies pay providers there.
